Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial

M Kanaka Prasad Rao; Lokesh Siddananjappa; Neetu Sidana; Ashish Deshmukh; Binayak Diwari; Indrasish Podder; Surendra Kumar; Ravindra  Mittal; Pavankumar  Daultani; Ashok Jaiswal; Monika Chinda; Sunil Naik; Lokesh Siddananjappa; Neetu Sidana; Ashish Deshmukh; Binayak Dwari; Indrasish Podder; Surendra Kumar; Dr. Ravindra  Mittal; Dr. Pavankumar  Daultani; Ashok  Jaiswal; Monika Chinda

doi:10.7759/cureus.60162

Enter your email address to receive your free PDF download.

Please note that by doing so you agree to be added to our monthly email newsletter distribution list.

Sign up for Cureus

or

First name

Last name

Email

Password

Specialty

Email Communication and Personal Data

Cureus personal data will never be sold to third parties and will only be used to enrich the user experience and contact you in direct relation to the application. I agree to opt in to this communication.

Learn more

Learn more

Learn more

Learn more

Learn more

Learn more

Ongoing Competitions

Enter your email address to receive your free PDF download.

Sign in to Cureus

Sign up for Cureus

Email Communication and Personal Data

Download Cureus Media Kit